Data on Postmenopausal Osteoporosis Described by a Researcher at 424 Military General Hospital (The comparative effect of teriparatide and denosumab on activins, follistatins and inhibins in women with postmenopausal osteoporosis).

A new report presents fresh data on postmenopausal osteoporosis, specifically focusing on the activins-follistatins-inhibins (AFI) hormonal system and its impact on bone metabolism. The study compared the effects of teriparatide and denosumab on the AFI system in postmenopausal women with osteoporosis. The results showed that teriparatide treatment increased levels of activin B and activin AB, as well as the ratios of activins to follistatin and activin AB to FSTL3. However, no changes were observed after denosumab treatment. The researchers concluded that further studies are needed to explore the potential role of activins in bone biology and their association with the effect of teriparatide on bone mineral density. [Extracted from the article]